PP
SUPN icon

Prudential plc’s Supernus Pharmaceuticals SUPN Stock Holding History

Prudential plc’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-242,100
Closed -$6.34M – 637
2021
Q1 		$6.34M Buy
+242,100
New +$6.77M 0.04% 269
2019
Q4 		– Sell
-90,855
Closed -$2.45M – 734
2019
Q3 		$2.45M Hold
90,855
– – 0.01% 469
2019
Q2 		$3M Buy
+90,855
New +$3.11M 0.01% 448

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Prudential plc's SUPN Position: Q2 2021 in Review

Prudential plc sold out of Supernus Pharmaceuticals (SUPN) in Q2 2021, closing a stake of 242,100 shares — an estimated $6.34M sold.

Prudential plc first reported a position in SUPN in Q2 2019 and held it in 3 quarters. The position peaked at $6.34M in Q1 2021. 226 funds tracked by Wall St. Rank hold SUPN as of Q2 2021.

  • Prudential plc reported no remaining Supernus Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Prudential plc sold 242,100 Supernus Pharmaceuticals shares in Q2 2021, an estimated $6.34M.
  • Prudential plc first reported a position in Supernus Pharmaceuticals in Q2 2019 and held it in 3 quarters.
  • Prudential plc's Supernus Pharmaceuticals position peaked at $6.34M in Q1 2021.
  • 226 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2021.

Based on Prudential plc's 13F filing for Q2 2021, filed 13 Aug 2021.